Literature DB >> 17321219

Power and sample size simulations for Randomized Play-the-Winner rules.

Paulo Guimaraes1, Yuko Palesch.   

Abstract

Response-adaptive randomization procedures, such as the Randomized Play-the-Winner (RPW), are treatment allocation rules for clinical trials that use available information on treatment outcomes to skew the allocation probability in favor of the treatment performing better thus far in the trial. Such allocation rules are based on the ethically desirable aim of reducing the share of patients allocated to the inferior treatment. This noble intent is overcome by statistical and logistical issues. One practical implementation obstacle of the RPW method is the estimation of required sample size and expected allocation shares. Unfortunately, this information is not readily available or easy to calculate. We present simulation results to provide a realistic assessment of the power and sample size required for successful implementation of the RPW rule for a study with primary outcome variable that is binary. Additionally, we discuss some practical approaches for sample size determination based on the RPW.

Entities:  

Mesh:

Year:  2007        PMID: 17321219     DOI: 10.1016/j.cct.2007.01.006

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  4 in total

1.  A simulation study for comparing testing statistics in response-adaptive randomization.

Authors:  Xuemin Gu; J Jack Lee
Journal:  BMC Med Res Methodol       Date:  2010-06-05       Impact factor: 4.615

Review 2.  Simulation methods to estimate design power: an overview for applied research.

Authors:  Benjamin F Arnold; Daniel R Hogan; John M Colford; Alan E Hubbard
Journal:  BMC Med Res Methodol       Date:  2011-06-20       Impact factor: 4.615

3.  N-of-1 Design and Its Applications to Personalized Treatment Studies.

Authors:  Tailiang Xie; Zhuoxin Yu
Journal:  Stat Biosci       Date:  2016-09-06

4.  The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.

Authors:  Andrew J Vickers; Peter T Scardino
Journal:  Trials       Date:  2009-03-05       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.